ICYMI: BTK Inhibitors in Cancer Patients with #COVID19— “The Winner Will be the One Who Controls That Chaos” (Napoleon Bonaparte). #AACRCovid https://t.co/eDbJrYjxyi https://t.co/6SZFfmCbk4
Quote a historical figure (Napoleon!) https://t.co/m1m7baWQLv or reference a literary classic (Gabriel García Márquez particularly popular) then add in “sex” and you get a catchy title (#8): “Sex in the Time of COVID-19” https://t.co/F2JRjGAe9Y
BTK inhibitors in cancer patients with #COVID19. https://t.co/qEc9c5qf1X
Perspective by Chong, et al. BTK Inhibitors in Cancer Patients with #COVID-19: “The Winner Will be the One Who Controls That Chaos” (Napoleon Bonaparte) #AACRCovid https://t.co/bk5Z8j4aAh https://t.co/d7PRXIRs9q
BTK Inhibitors in Cancer Patients with COVID-19: "The Winner Will be the One Who Controls That Chaos" (Napoleon Bonaparte) https://t.co/Ux3gN7ZfWL
BTK Inhibitors in Cancer Patients with COVID-19: “The Winner Will be the One Who Controls That Chaos” (Napoleon Bonaparte) https://t.co/kft6nYYA9e
RT @CllSociety: This is an important issue and will be helped when we have more data. https://t.co/tWdHGoft0T
RT @chadinabhan: To continue or discontinue BTKi in the era of #COVID19 A nice piece by @anthonymatomd @DrMDavids @mshadman & others. I’d…
RT @ASkarbnik: Adding to the BTKi story in COVID19. https://t.co/HJUspFXtXu
This is an important issue and will be helped when we have more data.
These authors suggest continued use of BTK inhibitors in #COVID19 patients with B-cell malignancies. BTKi block the activation of the Th1/M1 inflammatory cascade by the virus, whereas stopping BTKi increases the risk of rapid progression of the tumor. htt
BTK inhibitors in cancer patients with COVID19: "The winner will be the one who controls that chaos" (Napoleon Bonaparte). #lymphoma #lymsm https://t.co/5xXwUz4FjN
RT @chadinabhan: To continue or discontinue BTKi in the era of #COVID19 A nice piece by @anthonymatomd @DrMDavids @mshadman & others. I’d…
RT @chadinabhan: To continue or discontinue BTKi in the era of #COVID19 A nice piece by @anthonymatomd @DrMDavids @mshadman & others. I’d…
BTK inhibitors in cancer patients with COVID19: "The winner will be the one who controls that chaos" (Napoleon Bonaparte) https://t.co/l1SLrsxDzm
RT @chadinabhan: To continue or discontinue BTKi in the era of #COVID19 A nice piece by @anthonymatomd @DrMDavids @mshadman & others. I’d…
RT @DrRaulCordoba: #BTK inhibitors in #cancer patients with #COVID19: "The winner will be the one who controls that chaos" (Napoleon Bonapa…
To continue or discontinue BTKi in the era of #COVID19 A nice piece by @anthonymatomd @DrMDavids @mshadman & others. I’d say we still don’t know with certainty the best approach & more data/trials are needed. Excellent effort. 👏👍 https://t.co/M0aI
Adding to the BTKi story in COVID19.
RT @DrRaulCordoba: #BTK inhibitors in #cancer patients with #COVID19: "The winner will be the one who controls that chaos" (Napoleon Bonapa…
BTKis in cancer pts with #COVID19 . While waiting for clinical data... Published at CCR @anthonymatomd @DrMDavids @LRoekerMD
#BTK inhibitors in #cancer patients with #COVID19: "The winner will be the one who controls that chaos" (Napoleon Bonaparte) | Clinical Cancer Research by @anthonymatomd https://t.co/pKBJOYgvbh